IRIS UniCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.060
AS - Asia 1.990
EU - Europa 1.960
SA - Sud America 329
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 7.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.970
SG - Singapore 953
DE - Germania 665
CN - Cina 399
IT - Italia 323
SE - Svezia 315
BR - Brasile 253
VN - Vietnam 232
FR - Francia 135
GB - Regno Unito 89
FI - Finlandia 84
IN - India 84
UA - Ucraina 72
IE - Irlanda 64
BD - Bangladesh 60
ID - Indonesia 49
CA - Canada 48
HK - Hong Kong 45
JP - Giappone 45
RU - Federazione Russa 45
PL - Polonia 39
AR - Argentina 34
TR - Turchia 32
BE - Belgio 25
MX - Messico 24
CI - Costa d'Avorio 23
NL - Olanda 23
ZA - Sudafrica 18
EC - Ecuador 17
ES - Italia 17
IQ - Iraq 16
AT - Austria 15
IR - Iran 13
PK - Pakistan 12
SA - Arabia Saudita 10
CO - Colombia 8
CZ - Repubblica Ceca 8
LT - Lituania 8
VE - Venezuela 7
GR - Grecia 6
KR - Corea 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
KE - Kenya 3
PE - Perù 3
SN - Senegal 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.409
Salva come PNG Salva come JPEG
Città #
Ashburn 720
Singapore 606
Chandler 332
San Jose 219
New York 81
Beijing 80
Los Angeles 74
Rome 72
Hanoi 67
Ho Chi Minh City 66
Dublin 63
Ann Arbor 52
San Mateo 52
Wilmington 52
Helsinki 51
Dallas 50
Chicago 47
The Dalles 46
Cattolica 45
Lauterbourg 43
Jacksonville 42
Munich 42
Tokyo 42
Jakarta 41
Nanjing 41
Boston 36
Hong Kong 35
Warsaw 35
Nürnberg 33
Milan 30
Council Bluffs 29
Dearborn 29
Woodbridge 28
Frankfurt am Main 27
Moscow 27
Fairfield 26
Princeton 26
Santa Clara 26
Brussels 24
Matera 24
Abidjan 23
Houston 23
Orem 22
Shanghai 22
Hefei 21
Hyderabad 21
Nanchang 21
São Paulo 21
Marseille 20
Redwood City 19
Boardman 18
Izmir 18
Seattle 18
Denver 16
Augusta 14
Montreal 14
Redmond 14
Bremen 13
Hangzhou 13
Toronto 13
Buffalo 12
Falls Church 12
Johannesburg 12
Paris 12
Amsterdam 11
Brooklyn 11
Changsha 11
Da Nang 11
Phoenix 11
Stockholm 11
Chennai 10
Guangzhou 10
Lawrence 10
Leawood 10
Mexico City 10
Nuremberg 10
Poplar 10
St Louis 10
Turku 10
Atlanta 9
Hebei 9
Kent 9
London 9
Mountain View 9
Mumbai 9
Norwalk 9
Cambridge 8
Guayaquil 8
Newark 8
Potenza 8
Washington 8
Bari 7
Campinas 7
Lappeenranta 7
San Francisco 7
Zhengzhou 7
Ankara 6
Jeddah 6
Rio de Janeiro 6
Vienna 6
Totale 4.191
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 617
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
A phase II study of sunitinib in advanced hepatocellular carcinoma 278
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 210
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 202
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 201
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 194
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 190
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 161
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 161
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 159
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 158
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 156
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 155
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 154
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 149
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 149
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 148
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 146
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 142
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 141
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 138
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 133
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 132
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 128
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 125
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 124
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 123
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 119
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 119
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 114
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 114
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 108
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 104
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 103
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 102
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 100
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 89
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 85
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 85
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 83
Targeted therapy in advanced gastric carcinoma: The future is beginning 73
New life for retrospective study in the precision oncology era 68
Totale 7.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022453 37 16 12 64 27 11 7 68 17 37 61 96
2022/2023926 124 125 82 168 42 108 48 76 75 25 32 21
2023/2024862 20 90 28 14 12 71 236 263 2 16 38 72
2024/2025862 16 39 71 37 76 37 33 37 93 96 166 161
2025/20263.026 334 87 187 447 636 155 480 137 195 155 101 112
Totale 7.508